Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Durgesh Wankhede"'
Autor:
Tanwei Yuan, Durgesh Wankhede, Dominic Edelmann, Jakob Nikolas Kather, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge-Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Bläker, Hermann Brenner, Michael Hoffmeister
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105223- (2024)
Summary: Background: DNA methylation biomarkers in colorectal cancer (CRC) tissue hold potential as prognostic indicators. However, individual studies have yielded heterogeneous results, and external validation is largely absent. We conducted a compr
Externí odkaz:
https://doaj.org/article/518c1ff42f2c448688715029556177d7
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Tumor mutation burden (TMB) has been validated as a predictive biomarker for immunotherapy response and survival in numerous cancer types. Limited data is available on the inherent prognostic role of TMB in early-stage tumors. Objective:
Externí odkaz:
https://doaj.org/article/6a9ad020dfd44d29af31eaebf2b5e56c
Publikováno v:
Diagnostics, Vol 13, Iss 19, p 3043 (2023)
KRAS G12C mutation (mKRAS G12C) is the most frequent KRAS point mutation in non-small cell lung cancer (NSCLC) and has been proven to be a predictive biomarker for direct KRAS G12C inhibitors in advanced solid cancers. We sought to determine the prog
Externí odkaz:
https://doaj.org/article/be48c7fcef3d453c800fcdd3b69219bb
Autor:
Navin Kumar, Mukur Dipi Ray, D. N. Sharma, Rambha Pandey, Kanak Lata, Ashutosh Mishra, Durgesh Wankhede, Jyoutishman Saikia
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-7 (2020)
Abstract Background This study aims to analyze risk factors, clinical profiles, treatment protocols, and disease outcomes in histologically proven resectable vulvar cancer (VC) patients according to tumor stage. This is a retrospective analysis of a
Externí odkaz:
https://doaj.org/article/881051976e154b899f9aab377103ed9b
Publikováno v:
Vaccine. 41:1791-1798
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f440e49b69a95934f33eebb9f280853b
https://doi.org/10.1016/j.vaccine.2023.01.072
https://doi.org/10.1016/j.vaccine.2023.01.072
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 149:2179-2189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af59e545b596c5f1465ce7f62a63b8e7
https://doi.org/10.1007/s00432-022-04286-6
https://doi.org/10.1007/s00432-022-04286-6
Autor:
Durgesh Wankhede, Sandeep Grover
Publikováno v:
Annals of Surgical Oncology. 29:3709-3723
Evidence on the role of curative metastasectomy (CM) for malignant melanoma (MM) patients is limited, especially in the current era of effective systemic therapy. A systematic review and meta-analysis were performed to ascertain the role of CM compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8bfc15b9c459574b2fcdae00e63e97f
https://doi.org/10.1245/s10434-022-11351-4
https://doi.org/10.1245/s10434-022-11351-4
Publikováno v:
Cancers. 14(24)
Background: In breast, prostate, and other epithelial tumors, circulating tumor cells (CTC) in peripheral blood may predict survival. Our study evaluated the prognostic significance of baseline and postoperative CTC in patients with early non-small c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02834e21daf506537ff3dd3370459f32
https://pubmed.ncbi.nlm.nih.gov/36551601
https://pubmed.ncbi.nlm.nih.gov/36551601
Publikováno v:
Journal of cancer research and clinical oncology.
PD-1/PD-L1 inhibitors prolong survival in treatment-naïve, locally advanced, and metastatic non-small cell lung cancer (NSCLC) with positive PD-L1 expression ( 1%/ 50%). Recent evidence has suggested that tumors with 1% PD-L1 expression may also be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d85fffcdbef03f929932d894e2c023e8
https://pubmed.ncbi.nlm.nih.gov/35984491
https://pubmed.ncbi.nlm.nih.gov/35984491
Autor:
Durgesh Wankhede, Kanak Lata, Jyoutishman Saikia, Ashutosh Mishra, Dayanand Sharma, Navin Kumar, Rambha Pandey, Mukurdipi Ray
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-7 (2020)
Background This study aims to analyze risk factors, clinical profiles, treatment protocols, and disease outcomes in histologically proven resectable vulvar cancer (VC) patients according to tumor stage. This is a retrospective analysis of a prospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::526ea1e7820375978587ddd807eb0387
https://doaj.org/article/881051976e154b899f9aab377103ed9b
https://doaj.org/article/881051976e154b899f9aab377103ed9b